Japan should fundamentally overhaul its cost-effectiveness assessment (CEA) scheme while putting a hold on CEA-based price adjustments, a new ruling…
HOME > REGULATORY
REGULATORY
- EAD Director Kamata Calls for Early Price Settlements at Municipal Hospitals
February 21, 2013
- MHLW Eager to Submit Bill to Amend PAL to Diet by Summer, Councilor Hirayama Says
February 21, 2013
- Tokyo’s Katsushika Ward Allies with Wholesalers in Drug Procurement during Disasters
February 21, 2013
- Private-sector Members of Industrial Competitiveness Council Divided on Measures to Strengthen Innovation
February 20, 2013
- Prof. Morishita Calls for New Pricing System for Innovative Drugs; Doubling Prices Yielded by Current Cost Calculation Method
February 19, 2013
- 25 Companies Receive Approval for Generic Loxonin Tape, 11 Companies for Generic Calblock
February 19, 2013
- Regulatory Reform Council’s Priority Areas Include Health, Medicine; Discussion Topics to Be Set by Feb.-End
February 18, 2013
- Notification on Clinical Trial Documents and Records Cancels Previous Rules on Paper-Based “Original Documents and Duplicate Copies”
February 18, 2013
- MHLW Panel Kicks Off Discussion on New Rules for Online Drug Sales, Won’t Cover Ethical Products
February 15, 2013
- MHLW to Set Up “Central Liaison Council” this Fiscal Year to Unify Criteria for Reviewing Medical Bills
February 15, 2013
- CSIMC OKs NHI Price Listing of 17 APIs; Peak Sales of 34 Billion Yen Projected for Eliquis
February 14, 2013
- EAD Director Kamata Encourages Generic Makers to Develop Overseas Operations
February 13, 2013
- Denotas Chewable for Hypocalcemia Associated with Administration of Denosumab Passes PAFSC 1st Committee
February 12, 2013
- Off-Label Use of Predonine for DMD Now Being Reimbursed
February 12, 2013
- Equa Gets Go-Ahead for Additional Concurrent-Use Indications of Insulin and Other Hypoglycemic Agents: PAFSC 1st Committee
February 8, 2013
- PAFSC First Committee Recommends Approval for Japan’s First FD Treatment Acofide
February 8, 2013
- Health Sciences Council to Upgrade Committee on Immunization to “Department on Preventive Vaccination and Vaccines”
February 7, 2013
- NIHS to Accelerate Medical Innovation Research
February 7, 2013
- MHLW to Launch Panel on Feb. 14 to Set New Rules for Online OTC Drug Sales
February 6, 2013
- New Council on Conflicts of Interest Holds 1st Meeting, Some Doctors Say Disclosure of Individual Payments, Recipient Names “Hasty”
February 5, 2013
ページ
Global drug makers are forging ahead with therapies targeting lipoprotein(a), or Lp(a), a promising new approach to reducing cardiovascular risks.…
Japanese Prime Minister Sanae Takaichi said on October 14 that the government will consider the necessary measures for the FY2027…
Eli Lilly’s breast cancer drug Imulrio (imlunestrant) is finally joining Japan’s NHI price list on October 14, nearly 300 days…
The Wednesday TableShe had been on virtual calls since eight in the morning. The screen glowed. Her eyes burned. Plugged into Teams across time zones, she was digitally connected yet entirely isolated from the reality of Japan’s pharma market.She needed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…